BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38373011)

  • 1. FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome.
    Holmes-Hampton GP; Kumar VP; Valenzia K; Ghosh SP
    Radiat Res; 2024 May; 201(5):449-459. PubMed ID: 38373011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome.
    Patterson AM; Wu T; Chua HL; Sampson CH; Fisher A; Singh P; Guise TA; Feng H; Muldoon J; Wright L; Plett PA; Pelus LM; Orschell CM
    Radiat Res; 2021 Feb; 195(2):115-127. PubMed ID: 33302300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.
    McCart EA; Lee YH; Jha J; Mungunsukh O; Rittase WB; Summers TA; Muir J; Day RM
    Sci Rep; 2019 Feb; 9(1):2198. PubMed ID: 30778109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.
    Satyamitra M; Cary L; Dunn D; Holmes-Hampton GP; Thomas LJ; Ghosh SP
    Sci Rep; 2020 Feb; 10(1):1757. PubMed ID: 32019942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further Characterization of Multi-Organ DEARE and Protection by 16,16 Dimethyl Prostaglandin E2 in a Mouse Model of the Hematopoietic Acute Radiation Syndrome.
    Wu T; Pelus LM; Plett PA; Sampson CH; Chua HL; Fisher A; Feng H; Liu L; Li H; Ortiz M; Chittajallu S; Luo Q; Bhatwadekar AD; Meyer TB; Zhang X; Zhou D; Fischer KD; McKinzie DL; Miller SJ; Orschell CM
    Radiat Res; 2023 May; 199(5):468-489. PubMed ID: 37014943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome.
    Kurkjian CJ; Guo H; Montgomery ND; Cheng N; Yuan H; Merrill JR; Sempowski GD; Brickey WJ; Ting JP
    Sci Rep; 2017 Dec; 7(1):17355. PubMed ID: 29230065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice.
    Lee CL; Lento WE; Castle KD; Chao NJ; Kirsch DG
    Radiat Res; 2014 May; 181(5):445-51. PubMed ID: 24720754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice.
    Daniel AR; Lee CL; Oh P; Luo L; Ma Y; Kirsch DG
    Health Phys; 2020 Sep; 119(3):315-321. PubMed ID: 32175929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin mimetic stimulates bone marrow vascular and stromal niches to mitigate acute radiation syndrome.
    Vercellino J; Małachowska B; Kulkarni S; Bell BI; Shajahan S; Shinoda K; Eichenbaum G; Verma AK; Ghosh SP; Yang WL; Frenette PS; Guha C
    Stem Cell Res Ther; 2024 Apr; 15(1):123. PubMed ID: 38679747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primates.
    Brickey WJ; Caudell DL; Macintyre AN; Olson JD; Dai Y; Li S; Dugan GO; Bourland JD; O'Donnell LM; Tooze JA; Huang G; Yang S; Guo H; French MN; Schorzman AN; Zamboni WC; Sempowski GD; Li Z; Owzar K; Chao NJ; Cline JM; Ting JPY
    Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2122178120. PubMed ID: 38051771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body γ-irradiation.
    Moroni M; Ngudiankama BF; Christensen C; Olsen CH; Owens R; Lombardini ED; Holt RK; Whitnall MH
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):986-92. PubMed ID: 23845847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.
    Chua HL; Plett PA; Sampson CH; Katz BP; Carnathan GW; MacVittie TJ; Lenden K; Orschell CM
    Health Phys; 2014 Jan; 106(1):21-38. PubMed ID: 24276547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated hematopoietic recovery with angiotensin-(1-7) after total body radiation.
    Rodgers KE; Espinoza T; Roda N; Meeks CJ; Hill C; Louie SG; Dizerega GS
    Int J Radiat Biol; 2012 Jun; 88(6):466-76. PubMed ID: 22433112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Abbreviated Filgrastim Schedule on Survival and Hematopoietic Recovery after Irradiation in Four Mouse Strains with Different Radiosensitivity.
    Satyamitra M; Kumar VP; Biswas S; Cary L; Dickson L; Venkataraman S; Ghosh SP
    Radiat Res; 2017 Jun; 187(6):659-671. PubMed ID: 28362168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigation of Hematopoietic Syndrome of Acute Radiation Syndrome by 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) is Associated with Regulation of Systemic Inflammation in a Murine Model of Total-Body Irradiation.
    Kim YJ; Jeong J; Park K; Sohn KY; Yoon SY; Kim JW
    Radiat Res; 2021 Jul; 196(1):55-65. PubMed ID: 33914879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid.
    Deng W; Kimura Y; Gududuru V; Wu W; Balogh A; Szabo E; Thompson KE; Yates CR; Balazs L; Johnson LR; Miller DD; Strobos J; McCool WS; Tigyi GJ
    Radiat Res; 2015 Apr; 183(4):465-75. PubMed ID: 25807318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed renal injury in survivors of hematologic acute radiation syndrome.
    Gasperetti T; Frei A; Prasad Sharma G; Pierce L; Veley D; Szalewski N; Munjal Mehta S; Fish BL; Pleimes D; Himburg HA
    Int J Radiat Biol; 2023; 99(7):1130-1138. PubMed ID: 36688956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome.
    Landauer MR; Harvey AJ; Kaytor MD; Day RM
    J Radiat Res; 2019 May; 60(3):308-317. PubMed ID: 31038675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates.
    Krivokrysenko VI; Toshkov IA; Gleiberman AS; Krasnov P; Shyshynova I; Bespalov I; Maitra RK; Narizhneva NV; Singh VK; Whitnall MH; Purmal AA; Shakhov AN; Gudkov AV; Feinstein E
    PLoS One; 2015; 10(9):e0135388. PubMed ID: 26367124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
    Singh VK; Hauer-Jensen M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.